Home  -  About us  -  Editorial board  -  Search  -  Ahead of print  -  Current issue  -  Archives  -  Instructions  -  Subscribe  -  Contacts  -  Advertise - Login 

    Article Cited by others


Denosumab treatment for aggressive multiple recurrent familial central giant-cell granulomas

Rytkonen Eelis, Ottavainen Vuokko, Rytkönen Aleksi, Uusitalo Sanna, Lehenkari Petri, Sándor George K

Year : 2018| Volume: 8| Issue : 2 | Page no: 265-269

   This article has been cited by
1 Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study
Renato Luiz Maia Nogueira,Rafael Lima Verde Osterne,Renata de Matos Brito Lima Verde,Nayana Oliveira Azevedo,Renata Cordeiro Teixeira,Roberta Barroso Cavalcante
British Journal of Oral and Maxillofacial Surgery. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Treatment of central giant cell granuloma in children with denosumab
Michelle Choe,Valeria Smith,M. Fatih Okcu,Jade Wulff,Stephanie Gruner,Thierry A.G.M. Huisman,Rajkumar Venkatramani
Pediatric Blood & Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Off-label uses of denosumab in metabolic bone diseases
Stergios A. Polyzos,Polyzois Makras,Symeon Tournis,Athanasios D. Anastasilakis
Bone. 2019; : 115048
[Pubmed]  [Google Scholar] [DOI]


Read this article